Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.Peter Bross, Richard Pazdur, Sandip Kumar Roy et al.|PubMed|2001Cited by 861
End Points and United States Food and Drug Administration Approval of Oncology DrugsJohn R. Johnson, Richard Pazdur, Grant Williams|Journal of Clinical Oncology|2003Cited by 480
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.Martin H. Cohen, Richard Pazdur, Ann Staten et al.|PubMed|2002Cited by 469